Yueer Gene

company

About

Yueer is a genetic screening and diagnosis service provider, focusing on applying new genetic technology & international big data algorithms

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$50M
Industries
Big Data,Genetics,Health Care,Medical
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Yueer Gene has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Jun 2, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 2, 2022 Series B $50M 2 AstraZeneca Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Yueer Gene is funded by 2 investors. AstraZeneca and Haoreng Capital are the most recent investors.
Investor Name Lead Investor Funding Round
AstraZeneca Yes Series B
Haoreng Capital Series B